Recent Methods for the Viability Assessment of Bacterial Pathogens: Advances, Challenges, and Future Perspectives
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Trinh, Kieu The Loan | - |
dc.contributor.author | Lee, Nae Yoon | - |
dc.date.accessioned | 2022-10-28T02:40:15Z | - |
dc.date.available | 2022-10-28T02:40:15Z | - |
dc.date.created | 2022-10-28 | - |
dc.date.issued | 2022-09 | - |
dc.identifier.issn | 2076-0817 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/85871 | - |
dc.description.abstract | Viability assessment is a critical step in evaluating bacterial pathogens to determine infectious risks to public health. Based on three accepted viable criteria (culturability, metabolic activity, and membrane integrity), current viability assessments are categorized into three main strategies. The first strategy relies on the culturability of bacteria. The major limitation of this strategy is that it cannot detect viable but nonculturable (VBNC) bacteria. As the second strategy, based on the metabolic activity of bacteria, VBNC bacteria can be detected. However, VBNC bacteria sometimes can enter a dormant state that allows them to silence reproduction and metabolism; therefore, they cannot be detected based on culturability and metabolic activity. In order to overcome this drawback, viability assessments based on membrane integrity (third strategy) have been developed. However, these techniques generally require multiple steps, bulky machines, and laboratory technicians to conduct the tests, making them less attractive and popular applications. With significant advances in microfluidic technology, these limitations of current technologies for viability assessment can be improved. This review summarized and discussed the advances, challenges, and future perspectives of current methods for the viability assessment of bacterial pathogens. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | PATHOGENS | - |
dc.title | Recent Methods for the Viability Assessment of Bacterial Pathogens: Advances, Challenges, and Future Perspectives | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000856635200001 | - |
dc.identifier.doi | 10.3390/pathogens11091057 | - |
dc.identifier.bibliographicCitation | PATHOGENS, v.11, no.9 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85138467396 | - |
dc.citation.title | PATHOGENS | - |
dc.citation.volume | 11 | - |
dc.citation.number | 9 | - |
dc.contributor.affiliatedAuthor | Trinh, Kieu The Loan | - |
dc.contributor.affiliatedAuthor | Lee, Nae Yoon | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | viability assessment | - |
dc.subject.keywordAuthor | viable but nonculturable bacteria (VBNC) | - |
dc.subject.keywordAuthor | culturability | - |
dc.subject.keywordAuthor | metabolic activity | - |
dc.subject.keywordAuthor | membrane integrity | - |
dc.subject.keywordPlus | PROPIDIUM MONOAZIDE | - |
dc.subject.keywordPlus | STAPHYLOCOCCUS-AUREUS | - |
dc.subject.keywordPlus | FLUORESCEIN DIACETATE | - |
dc.subject.keywordPlus | MICROFLUIDIC DEVICE | - |
dc.subject.keywordPlus | ESCHERICHIA-COLI | - |
dc.subject.keywordPlus | RAPID DETECTION | - |
dc.subject.keywordPlus | MILK POWDER | - |
dc.subject.keywordPlus | PMA-QPCR | - |
dc.subject.keywordPlus | PCR | - |
dc.subject.keywordPlus | ATP | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.relation.journalWebOfScienceCategory | Microbiology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.